Ondansetron Recall: Preferred Pharmaceuticals ODT Tablets
Announced 2026-04-15 · FDA
The FDA recall involves 575 1x10 foil blister packs of Ondansetron ODT Tablets 4 mg repackaged by Preferred Pharmaceuticals, Inc., with Glenmark as the original manufacturer, distributed nationwide in the USA. The defect is blister packs that are not fully sealed, causing tablets to fall out. Affected lots are Lot J1325J and Lot I1725P, with expiration date 4/30/2027.
| Brand | Preferred Pharmaceuticals, Inc. |
|---|---|
| Product | Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01 |
| Reason | Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale. |
| Severity | moderate |
| Units affected | 720 |
| Distribution | Natinowide in the USA |
| Agency | FDA |
| Recall / campaign no. | Lot: J1325J, I1725P, EXP Date: 4/30/2027. |
WHAT YOU SHOULD DO
- Do not use any remaining packs from Lot J1325J or Lot I1725P (expires 4/30/2027).
- Contact Preferred Pharmaceuticals or the place of purchase for instructions on refunds or replacement.
- Return recalled packs to the place of purchase or dispose of them according to local guidelines.
- Check for updates from the FDA or the company and seek medical advice if you have concerns after using the product.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.